Culture, Economy & Business, Health & Environment, International, Politics

Seeds of Change: Taliban Now in the Weed Business

CPharm International (ECI), a German research and development firm, has said it is planning a multi-million-dollar investment in Taliban-controlled Afghanistan, with the aim of producing weed for medical purposes.

Following an unfortunate case of mistaken identity in late 2021, Vice media agency tracked down a German company, CPharm International (ECI), which has struck a deal with the Taliban.

Last year, a tweet from the Afghan Ministry of the Interior claimed that a firm called “Cpharm” had met with Taliban officials and would invest $450 million in Afghanistan to set up a “hashish-processing” operation. The media wrongly identified a small Australian medical consulting firm of the same name; they vehemently denied the link with the Taliban. Read more…

You Might Also Like